| Location | Boston, MA |
Aktis Oncology, Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. Aktis' most advanced program, AKY-1189, is a miniprotein radioconjugate targeting Nectin-4, with multi-indication potential across multiple tumor types, including locally advanced or metastatic urothelial cancer, breast cancer, non-small cell lung cancer, colorectal cancer, cervical cancer, and head and neck cancer. Aktis' second pipeline program, AKY-2519, is a miniprotein radioconjugate targeting B7-H3 expressing tumors, including prostate, lung and other solid tumors. Aktis has a strategic collaboration with Eli Lilly and Company to leverage its miniprotein platform to develop novel radioconjugates outside of Aktis' proprietary pipeline.
Aktis Oncology is seeking a Clinical Trial Associate/Sr. Clinical Trial Associate. This role will report to the Senior Director, Clinical Operations.
Responsibilities
The Clinical Trial Associate (CTA) will support the planning, execution, and documentation of clinical trials involving radiopharmaceutical agents. Working under the direction of the Clinical Trial Manager or Clinical Operations Lead, the CTA will assist with key trial activities including study start-up, tracking, document management, and coordination with external vendors and clinical sites. This role is critical for maintaining quality, compliance, and operational efficiency across clinical programs.
This role will drive several areas of strategic importance to Aktis:
Qualifications
Aktis Oncology is an Equal Opportunity Employer and does not discriminate on the basis of race, religion, color, sex, gender identity or expression, sexual orientation, age, disability, national origin, veteran status, or any other basis covered by appropriate law. Aktis Oncology is committed to promoting and maintaining a work environment in which all applicants, employees, and other individuals are treated with dignity and respect, free from unlawful harassment, discrimination, or retaliation.